Sign up to save your podcasts
Or
Share Dr. Kai Keen Shiu
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Dr. Kai Keen Shiu
Investigating pembrolizumab in microsatellite-instability-high advanced colorectal cancer, Dr. Kai Keen Shiu shares the latest results of the phase 3 KEYNOTE-177 study and what these results mean for other colorectal cancer populations moving forward.
View all episodes
By Ariez PublishingInvestigating pembrolizumab in microsatellite-instability-high advanced colorectal cancer, Dr. Kai Keen Shiu shares the latest results of the phase 3 KEYNOTE-177 study and what these results mean for other colorectal cancer populations moving forward.